AbstractWe investigated the formation of F2-isoprostanes produced by non-enzymatic peroxidation of arachidonic acid during rabbit aortic endothelial cell-mediated oxidation of low density lipoprotein (LDL). Free and total (sum of free and esterified) levels of F2-isoprostanes were measured using a solid-phase extraction procedure and gas chromatography-mass spectrometry. Free levels of F2-isoprostanes in native LDL were 0.06 ± 0.03 ng/mg protein (n = 4), whereas total levels were 0.28 ± 0.09 ng/mg protein (n = 4). Both free and total levels of the isoprostanes were found to increase during the oxidation. 8-epi-PGF2α was the major isoprostane formed (free and total concentrations after 24 h, 2.50 ± 0.24 and 6.42 ± 1.36 ng/mg protein (n = 4),...
F2-isoprostanes are not just markers of oxidative stress. The discovery of F2-isoprostanes as specif...
Oxygenated lipid products of non-cyclooxygenase derivatives, namely, prostanoids such as, isoprostan...
AbstractOxidatively modified low-density-lipoprotein (LDL) might contribute to the atherosclerotic p...
AbstractWe investigated the formation of F2-isoprostanes produced by non-enzymatic peroxidation of a...
Increased lipid peroxidation has been identified as a key mechanism for the development of atheroscl...
F-2-Isoprostanes are prostaglandin (PG) isomers formed in situ in cell membranes by peroxidation of ...
F2-Isoprostanes are prostaglandin (PG) isomers formed in situ in cell membranes by peroxidation of a...
Levuglandin (LG) E2, a cytotoxic seco prostanoic acid co-generated with prostaglandins by nonenzymat...
Oxidatively-modified low-density lipoproteins (LDL) contribute to the onset of the atherosclerotic d...
Interactions between vascular endothelium and low density lipoprotein (LDL) have been implicated in ...
<div><p>Cellular systems are essential model systems to study reactive oxygen species and oxidative ...
Oxidation of low density lipoprotein (LDL) in atherosclerotic lesions may be involved in converting ...
An important event in the formation of atherosclerotic lesions is the uptake of modified low density...
Vasodilation mediated by endothelium-derived relaxing factor (EDRF) is accounted for by the release ...
F2-isoprostanes are complex metabolites of arachidonic acid generated via nonenzymatic free radical ...
F2-isoprostanes are not just markers of oxidative stress. The discovery of F2-isoprostanes as specif...
Oxygenated lipid products of non-cyclooxygenase derivatives, namely, prostanoids such as, isoprostan...
AbstractOxidatively modified low-density-lipoprotein (LDL) might contribute to the atherosclerotic p...
AbstractWe investigated the formation of F2-isoprostanes produced by non-enzymatic peroxidation of a...
Increased lipid peroxidation has been identified as a key mechanism for the development of atheroscl...
F-2-Isoprostanes are prostaglandin (PG) isomers formed in situ in cell membranes by peroxidation of ...
F2-Isoprostanes are prostaglandin (PG) isomers formed in situ in cell membranes by peroxidation of a...
Levuglandin (LG) E2, a cytotoxic seco prostanoic acid co-generated with prostaglandins by nonenzymat...
Oxidatively-modified low-density lipoproteins (LDL) contribute to the onset of the atherosclerotic d...
Interactions between vascular endothelium and low density lipoprotein (LDL) have been implicated in ...
<div><p>Cellular systems are essential model systems to study reactive oxygen species and oxidative ...
Oxidation of low density lipoprotein (LDL) in atherosclerotic lesions may be involved in converting ...
An important event in the formation of atherosclerotic lesions is the uptake of modified low density...
Vasodilation mediated by endothelium-derived relaxing factor (EDRF) is accounted for by the release ...
F2-isoprostanes are complex metabolites of arachidonic acid generated via nonenzymatic free radical ...
F2-isoprostanes are not just markers of oxidative stress. The discovery of F2-isoprostanes as specif...
Oxygenated lipid products of non-cyclooxygenase derivatives, namely, prostanoids such as, isoprostan...
AbstractOxidatively modified low-density-lipoprotein (LDL) might contribute to the atherosclerotic p...